NAD(P)H oxidase in the failing human heart

Author： Krijnen P.A.J.   Meischl C.   Visser C.A.   Hack C.E.   Niessen H.W.M.   Roos D.  

Publisher： Elsevier

ISSN： 0735-1097

Source： Journal of the American College of Cardiology, Vol.42, Iss.12, 2003-12, pp. : 2170-2171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

NADPH oxidose in the failing human heart: Reply

By Shah A.M.   Heymes C.  

Journal of the American College of Cardiology, Vol. 42, Iss. 12, 2003-12 ,pp. : 2171-2172

Elsevier

Access to resources Recommend Favorite

The C242T Polymorphism of the NAD(P)H Oxidase p22phox Subunit Is Associated with an Enhanced Risk for Cerebrovascular Disease at a Young Age

By  

Cerebrovascular Diseases, Vol. 26, Iss. 4, 2008-09 ,pp. : 430-433

Karger

Access to resources Recommend Favorite

NAD(P)H Oxidases and Their Relevance to Atherosclerosis

By Sorescu D.   Szocs K.   Griendling K.K.  

Trends in Cardiovascular Medicine, Vol. 11, Iss. 3, 2001-04 ,pp. : 124-131

Elsevier

Access to resources Recommend Favorite

The NAD(P)H Oxidase Inhibitor Apocynin Improves Endothelial NO/Superoxide Balance and Lowers Effectively Blood Pressure in Spontaneously Hypertensive Rats: Comparison to Calcium Channel Blockade

By Baumer Anselm T.   Kruger Christian A.   Falkenberg Juliane   Freyhaus Henrik Ten   Rosen Renate   Fink Klaus   Rosenkranz Stephan  

Clinical and Experimental Hypertension, Vol. 29, Iss. 5, 2007-06 ,pp. : 287-299

Informa Healthcare

Access to resources Recommend Favorite

Oxidative stress-associated vascular aging is independent of the protein kinase C/NAD(P)H oxidase pathway

By Bachschmid M.   van der Loo B.   Schuler K.   Labugger R.   Thurau S.   Eto M.   Kilo J.   Holz R.   Luscher T.F.   Ullrich V.  

Archives of Gerontology and Geriatrics, Vol. 38, Iss. 2, 2004-03 ,pp. : 181-190

Elsevier

Access to resources Recommend Favorite